BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2560529)

  • 1. [Immunohistochemical study of cancer-associated carbohydrate antigens in carcinoma of the biliary tract].
    Sasaki R
    Nihon Geka Gakkai Zasshi; 1989 Dec; 90(12):1976-88. PubMed ID: 2560529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer].
    Anzai K; Kurihara M; Izumi T
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1437-47. PubMed ID: 2212836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
    Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Japanese Study Group of Hepatolithiasis.
    Sasaki M; Morita T; Hoso M; Nakanuma Y; Tanimura H
    Hepatology; 1996 Feb; 23(2):258-63. PubMed ID: 8591850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gallbladder cancer: immunohistochemical expression of CA-19-9, epithelial membrane antigen, dupan-2 and carcinoembryonic antigen].
    Roa I; Araya JC; Shiraisch T; Yatani R; Wistuba I; Villaseca M; de Aretxabala X
    Rev Med Chil; 1992 Nov; 120(11):1218-26. PubMed ID: 1340939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice.
    Ohshio G; Manabe T; Watanabe Y; Endo K; Kudo H; Suzuki T; Tobe T
    Am J Gastroenterol; 1990 Oct; 85(10):1370-6. PubMed ID: 2220731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of carcinoembryonic antigen, carbohydrate antigen 19-9 and cytology of bile in diagnosis of biliary and pancreatic cancer].
    Matsuda M; Shimizu Y; Chikamatsu E; Takayanagi K; Ishigure H; Murakami S; Odani K
    Nihon Geka Gakkai Zasshi; 1991 Jun; 92(6):716-21. PubMed ID: 1886576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies.
    Brockmann J; Emparan C; Hernandez CA; Sulkowski U; Dietl KH; Menzel J; Wolters H; Glodny B; Senninger N
    Anticancer Res; 2000; 20(6D):4941-7. PubMed ID: 11326643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
    Okami J; Dohno K; Sakon M; Iwao K; Yamada T; Yamamoto H; Fujiwara Y; Nagano H; Umeshita K; Matsuura N; Nakamori S; Monden M
    Clin Cancer Res; 2000 Jun; 6(6):2326-32. PubMed ID: 10873083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical staining of pancreatic cancer with CA19-9, KM01, unabsorbed CEA, and absorbed CEA. A comparison with normal pancreas and chronic pancreatitis.
    Shimizu M; Saitoh Y; Ohyanagi H; Itoh H
    Arch Pathol Lab Med; 1990 Feb; 114(2):195-200. PubMed ID: 1689141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma of the ampulla of Vater: expression of cancer-associated antigens inversely correlated with prognosis.
    Kamisawa T; Fukayama M; Koike M; Tabata I; Egawa N; Isawa T; Okamoto A; Hayashi Y
    Am J Gastroenterol; 1988 Oct; 83(10):1118-23. PubMed ID: 3048082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical expression of the carcinoembryonic antigen in gallbladder cancer].
    Roa I; Araya JC; Wistuba I; De Aretxabala X; Salinas C; Mauriz A; Villaseca M
    Rev Med Chil; 1991 Feb; 119(2):129-36. PubMed ID: 1824154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of a tumor marker NCC-ST-439 in breast cancer--a comparative study with CA 15-3, CEA and TPA].
    Okamura Y; Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1279-85. PubMed ID: 2069399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study on hepatic tumors--KM01 stains compared with AFP, CEA, CA19-9 and RAS P21.
    Hanabata M; Ohyanagi H; Saitoh Y; Itoh H
    Kobe J Med Sci; 1991 Apr; 37(2):81-96. PubMed ID: 1717740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in gastric cancer patients].
    Tabuchi Y; Deguchi H; Saitoh Y
    Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1181-91. PubMed ID: 3185486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
    Nakahara M; Fujisawa K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An investigation of the mode of local spreading of biliary tract carcinoma to microvascular and neural structure].
    Takahashi M
    Hokkaido Igaku Zasshi; 1996 Jul; 71(4):449-62. PubMed ID: 8809570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of tumor progression in human gallbladder: flow cytometry, CEA, and CA 19-9 levels in bile and serum in different stages of gallbladder disease.
    Strom BL; Iliopoulos D; Atkinson B; Herlyn M; West SL; Maislin G; Saul S; Varello MA; Rodriguez-Martinez HA; Rios-Dalenz J
    J Natl Cancer Inst; 1989 Oct; 81(20):1575-80. PubMed ID: 2795683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histogenesis of gallbladder cancer with special reference to metaplastic changes and distribution of various mucins and CEA].
    Inada A; Konishi F; Yamamichi N; Ito H
    Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):894-906. PubMed ID: 2796960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in patients with colorectal cancer].
    Deguchi H; Tabuchi Y; Saitoh Y
    Nihon Geka Gakkai Zasshi; 1988 May; 89(5):671-83. PubMed ID: 3166103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.